chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills
Clinical narrative: Feeling weak; Chills; This spontaneous case was reported by a physician and describes the occurrence of ASTHENIA (Feeling weak) and CHILLS (Chills) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included Diabetes.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced ASTHENIA (Feeling weak) and CHILLS (Chills). At the time of the report, ASTHENIA (Feeling weak) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication include oral medication for diabetes and PD OXYGEN No treatment information provided.  This case was linked to MOD-2021-014421, MOD-2021-014393 (E2B Linked Report).; Sender's Comments:  MOD-2021-014421:same reporter, different patient. MOD-2021-014393:same reporter, different patient.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Discomfort
Clinical narrative: Pressure sensitivity in left underarm; pain in left underarm; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Pressure sensitivity in left underarm) and AXILLARY PAIN (pain in left underarm) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (Pressure sensitivity in left underarm) and AXILLARY PAIN (pain in left underarm). At the time of the report, DISCOMFORT (Pressure sensitivity in left underarm) and AXILLARY PAIN (pain in left underarm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided    Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pruritus
Clinical narrative: itchiness; a little pain; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness) and PAIN (a little pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchiness) and PAIN (a little pain). At the time of the report, PRURITUS (itchiness) and PAIN (a little pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itchy rash occurring on Face, Arms, and Legs; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy rash occurring on Face, Arms, and Legs) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history recorded).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PRURITUS (itchy rash occurring on Face, Arms, and Legs). At the time of the report, PRURITUS (itchy rash occurring on Face, Arms, and Legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provide Treated with Allegra 180mg, Benadryl 25mg, Zyrtec 10mg, epcid 40mg
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort
Clinical narrative: little bit of soreness; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (little bit of soreness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergic reaction to excipient (Patient is being allergic to polyethylene glycol.).    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (little bit of soreness). At the time of the report, DISCOMFORT (little bit of soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Lymphadenopathy
Clinical narrative: weakness; swelling of the lymph nodes; Headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), LYMPHADENOPATHY (swelling of the lymph nodes), HEADACHE (Headache) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), LYMPHADENOPATHY (swelling of the lymph nodes), HEADACHE (Headache) and CHILLS (chills). At the time of the report, ASTHENIA (weakness), LYMPHADENOPATHY (swelling of the lymph nodes), HEADACHE (Headache) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided   This case was linked to MOD-2021-014394, MOD-2021-014393 (E2B Linked Report).; Sender's Comments:  MOD-2021-014394:same reporter, different patient MOD-2021-014393:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Vaccination site pain, Vaccination site swelling
Clinical narrative: Mild swelling at injection site 12 hours after getting the Moderna COVID-19 vaccine (January; Chills 12 hours after getting the Moderna COVID-19 vaccine (January 22nd, 2021); Persisting and intense headache 12 hours after getting the Moderna COVID-19 vaccine (January; Tenderness 12 hours after getting the Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of HEADACHE (Persisting and intense headache 12 hours after getting the Moderna COVID-19 vaccine (January), VACCINATION SITE PAIN (Tenderness 12 hours after getting the Moderna COVID-19 vaccine), VACCINATION SITE SWELLING (Mild swelling at injection site 12 hours after getting the Moderna COVID-19 vaccine (January) and CHILLS (Chills 12 hours after getting the Moderna COVID-19 vaccine (January 22nd, 2021)) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced HEADACHE (Persisting and intense headache 12 hours after getting the Moderna COVID-19 vaccine (January). On an unknown date, the patient experienced VACCINATION SITE PAIN (Tenderness 12 hours after getting the Moderna COVID-19 vaccine), VACCINATION SITE SWELLING (Mild swelling at injection site 12 hours after getting the Moderna COVID-19 vaccine (January) and CHILLS (Chills 12 hours after getting the Moderna COVID-19 vaccine (January 22nd, 2021)). At the time of the report, HEADACHE (Persisting and intense headache 12 hours after getting the Moderna COVID-19 vaccine (January), VACCINATION SITE PAIN (Tenderness 12 hours after getting the Moderna COVID-19 vaccine), VACCINATION SITE SWELLING (Mild swelling at injection site 12 hours after getting the Moderna COVID-19 vaccine (January) and CHILLS (Chills 12 hours after getting the Moderna COVID-19 vaccine (January 22nd, 2021)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported Treatment INCLUDE Tylenol
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site warmth
Clinical narrative: Arm have a big red nod; feels like there is a fever in her arms; Arm have a big red nod; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Arm have a big red nod), VACCINATION SITE WARMTH (feels like there is a fever in her arms) and VACCINATION SITE ERYTHEMA (Arm have a big red nod) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE MASS (Arm have a big red nod), VACCINATION SITE WARMTH (feels like there is a fever in her arms) and VACCINATION SITE ERYTHEMA (Arm have a big red nod). At the time of the report, VACCINATION SITE MASS (Arm have a big red nod), VACCINATION SITE WARMTH (feels like there is a fever in her arms) and VACCINATION SITE ERYTHEMA (Arm have a big red nod) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Lymph node pain
Clinical narrative: Discomfort on the left armpit; Discomfort on the left lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Discomfort on the left armpit) and LYMPH NODE PAIN (Discomfort on the left lymph nodes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced DISCOMFORT (Discomfort on the left armpit) and LYMPH NODE PAIN (Discomfort on the left lymph nodes). At the time of the report, DISCOMFORT (Discomfort on the left armpit) and LYMPH NODE PAIN (Discomfort on the left lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided    Reporter did not allow further contact
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Contusion, Muscle fatigue, Myalgia, Pain in extremity
Clinical narrative: muscle tiredness in muscles of arms, legs; Joint achiness/ Soreness in right shoulder area; Injection site area sore; mild Muscle achiness,; Arm was sore; Feels like a bruise; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), CONTUSION (Feels like a bruise), MUSCLE FATIGUE (muscle tiredness in muscles of arms, legs), ARTHRALGIA (Joint achiness/ Soreness in right shoulder area) and VACCINATION SITE PAIN (Injection site area sore) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included GERD. Concurrent medical conditions included Cholesterol blood excessive, Pollen allergy, Dust allergy, Allergy to animal dander, Penicillin allergy, Allergy to antibiotic, Pollen allergy, Dust allergy, Allergy to animal dander, Penicillin allergy and Sulfonamide allergy. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), METHOCARBAMOL (ROBAXIN) and FAMOTIDINE (PEPCID AC) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore), CONTUSION (Feels like a bruise), ARTHRALGIA (Joint achiness/ Soreness in right shoulder area), VACCINATION SITE PAIN (Injection site area sore) and MYALGIA (mild Muscle achiness,). On 17-Jan-2021, the patient experienced MUSCLE FATIGUE (muscle tiredness in muscles of arms, legs). At the time of the report, PAIN IN EXTREMITY (Arm was sore), CONTUSION (Feels like a bruise), MUSCLE FATIGUE (muscle tiredness in muscles of arms, legs), ARTHRALGIA (Joint achiness/ Soreness in right shoulder area), VACCINATION SITE PAIN (Injection site area sore) and MYALGIA (mild Muscle achiness,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: muscle tiredness in muscles of arms, legs; Joint achiness/ Soreness in right shoulder area; Injection site area sore; mild Muscle achiness,; Arm was sore; Feels like a bruise; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), CONTUSION (Feels like a bruise), MUSCLE FATIGUE (muscle tiredness in muscles of arms, legs), ARTHRALGIA (Joint achiness/ Soreness in right shoulder area) and VACCINATION SITE PAIN (Injection site area sore) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included GERD. Concurrent medical conditions included Cholesterol blood excessive, Pollen allergy, Dust allergy, Allergy to animal dander, Penicillin allergy, Allergy to antibiotic, Pollen allergy, Dust allergy, Allergy to animal dander, Penicillin allergy and Sulfonamide allergy. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), METHOCARBAMOL (ROBAXIN) and FAMOTIDINE (PEPCID AC) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore), CONTUSION (Feels like a bruise), ARTHRALGIA (Joint achiness/ Soreness in right shoulder area), VACCINATION SITE PAIN (Injection site area sore) and MYALGIA (mild Muscle achiness,). On 17-Jan-2021, the patient experienced MUSCLE FATIGUE (muscle tiredness in muscles of arms, legs). At the time of the report, PAIN IN EXTREMITY (Arm was sore), CONTUSION (Feels like a bruise), MUSCLE FATIGUE (muscle tiredness in muscles of arms, legs), ARTHRALGIA (Joint achiness/ Soreness in right shoulder area), VACCINATION SITE PAIN (Injection site area sore) and MYALGIA (mild Muscle achiness,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Arm hurts when raised past shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Arm hurts when raised past shoulder) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. FIN#349887743500) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Arm hurts when raised past shoulder). At the time of the report, ARTHRALGIA (Arm hurts when raised past shoulder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: sore; red itchy reaction around the injection site; red patch; Itchy; Mild sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Mild sore arm), VACCINATION SITE ERYTHEMA (red itchy reaction around the injection site; red patch), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE PAIN (sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (Mild sore arm). On 25-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red itchy reaction around the injection site; red patch) and VACCINATION SITE PRURITUS (Itchy). On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore). At the time of the report, VACCINATION SITE PAIN (Mild sore arm), VACCINATION SITE ERYTHEMA (red itchy reaction around the injection site; red patch), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE PAIN (sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Nausea, Pyrexia
Clinical narrative: Chills; Fever; Nausea; Vomiting; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), VOMITING (Vomiting) and FATIGUE (Fatigue) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), VOMITING (Vomiting) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), VOMITING (Vomiting) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Body temperature: 99.6 (Inconclusive) 99.6F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Outcome of the events updated to resolved. Patient declined further follow-ups
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Chills; Fever; Nausea; Vomiting; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), VOMITING (Vomiting) and FATIGUE (Fatigue) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), VOMITING (Vomiting) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), VOMITING (Vomiting) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Body temperature: 99.6 (Inconclusive) 99.6F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Outcome of the events updated to resolved. Patient declined further follow-ups
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash pruritic, Vaccination site rash
Clinical narrative: very rash itchy on the neck; rash on the chest that is hardly itchy at all; Rash quite large at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (very rash itchy on the neck), PRURITUS (rash on the chest that is hardly itchy at all) and VACCINATION SITE RASH (Rash quite large at the injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included SPIRONOLACTONE (ALDACTONE A), MINOXIDIL, LEVOTHYROXINE SODIUM (SYNTHROID), SOLIFENACIN SUCCINATE (VESICARE), MIRABEGRON (MYRBETRIQ) and VENLAFAXINE for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced RASH PRURITIC (very rash itchy on the neck), PRURITUS (rash on the chest that is hardly itchy at all) and VACCINATION SITE RASH (Rash quite large at the injection site). At the time of the report, RASH PRURITIC (very rash itchy on the neck), PRURITUS (rash on the chest that is hardly itchy at all) and VACCINATION SITE RASH (Rash quite large at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Sinusitis
Clinical narrative: Sinus infection; very bad cough; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection) and COUGH (very bad cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SINUSITIS (Sinus infection) and COUGH (very bad cough). At the time of the report, SINUSITIS (Sinus infection) and COUGH (very bad cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included unspecified antibiotics and unspecified steroids. No concomitant medications were provided by reporter.   Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: arm is red; arm is swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm is red) and VACCINATION SITE SWELLING (arm is swollen) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included VITAMIN D3 and CALCIUM for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (arm is red) and VACCINATION SITE SWELLING (arm is swollen). At the time of the report, VACCINATION SITE ERYTHEMA (arm is red) and VACCINATION SITE SWELLING (arm is swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided by reporter.   Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch at the injection site), VACCINATION SITE PRURITUS (itchy knot at the injection site) and VACCINATION SITE ERYTHEMA (Red knot at the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0004M20A) for COVID-19 vaccination. No Medical History information was reported. On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch at the injection site), VACCINATION SITE PRURITUS (itchy knot at the injection site) and VACCINATION SITE ERYTHEMA (Red knot at the injection site). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (warm to the touch at the injection site), VACCINATION SITE PRURITUS (itchy knot at the injection site) and VACCINATION SITE ERYTHEMA (Red knot at the injection site) was resolving.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information was provided. Treatment information included Benadryl and Ice pack.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: experienced a rash; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore) and VACCINATION SITE RASH (experienced a rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039KZOA and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (arm was sore). On an unknown date, the patient experienced VACCINATION SITE RASH (experienced a rash). At the time of the report, VACCINATION SITE PAIN (arm was sore) outcome was unknown and VACCINATION SITE RASH (experienced a rash) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Ultrasound scan
Clinical narrative: maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) in a 30-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (6 glasses of wine/week). Concurrent medical conditions included Meniere's disease (Recent change: Intermittent Vertigo issues and Loss of hearing.) since 15-Jun-2018. Concomitant products included CISAPRIDE (PLEXUS [CISAPRIDE]), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and CALCIUM for Pregnancy.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was in September 2020 and the estimated date of delivery was 01-Jul-2021. On 11-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 11-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Ultrasound scan: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: fatigue; Headache; muscle pain; joint pain; chills; Nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), HEADACHE (Headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and CHILLS (chills) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On 10-Feb-2021, the patient experienced FATIGUE (fatigue), HEADACHE (Headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (Nausea) and VOMITING (vomiting).   On 11-Feb-2021, FATIGUE (fatigue), HEADACHE (Headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (Nausea) and VOMITING (vomiting) had resolved.      Treatment medication not provided. Concomitant medication not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Non-significant information
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: fatigue; Headache; muscle pain; joint pain; chills; Nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), HEADACHE (Headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and CHILLS (chills) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On 10-Feb-2021, the patient experienced FATIGUE (fatigue), HEADACHE (Headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (Nausea) and VOMITING (vomiting).   On 11-Feb-2021, FATIGUE (fatigue), HEADACHE (Headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (Nausea) and VOMITING (vomiting) had resolved.      Treatment medication not provided. Concomitant medication not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Non-significant information
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Non-stop fevers; A spontaneous report was received from a consumer who was also a 72-years-old male patient who received Moderna's COVID-19 vaccine and experienced  non-stop fevers of 98 and above, but not 100.  Patient's medical history was not provided, and no report on concomitant medicines.   On 8/Feb/2021 2020, approximately 2 day prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 9/Feb/2021, the patient felt non-stop fevers of 98 and above. symptoms were resolving.   No Treatment was taken by the patient  Action taken with mRNA-1273 was not reported.  The outcome of the events, non-stop fevers of 98 and above  was considered to resolving.
Sex: F
Vaccine: COVID19
Symptoms: Hypoacusis, Tinnitus
Clinical narrative: tone in her ear; can't hear; This spontaneous report was received from consumer on 11-FEB-2021, concerning a 67 year old female patient who was administered Moderna COVID-19 vaccine9( mRNA-1273). The patient experienced tone in ear and hearing problem  The patient's medical history was not provided and Concomitant  medication was not provided. The patient received suspect product  mRNA-1273 on 14/JAN/2021, prior to the onset event, the patient received their first dose of mRNA-1273 (lot number:029L20A) intramuscularly  for prophylaxis of COVID-19 infection lab data note provided event is tone in her ear, loud ringing, cant,hear out come of the even unknown  The patient received the first dose of moderna vaccine on 14Jan2021 and today have to receive the second dose. Informed that the same week from the first shot she started to had a tone in her ear, can't hear, she feels a loud ringing. Today still on going and getting louder every day. She does not know if it is because of the vaccine or not. Action taken with the  dose of mRNA-1273  in response to the events was not reported
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Tested positive for Covid 19; A Spontaneous report was received from consumer concerning a female patient of 66 age who received Moderna COVID-19 vaccine (m-RNA-1273) and Tested positive for Covid 19.  The patient has no medical history and no relevant concomitant medications.   On 26-Jan-2021, prior to the onset of the events the patient received their first of dose of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  Treatment information was not provided.   The events positive for Covid 19 were unknown. The outcome of the events is unknown.   Action taken with mRNA-1273 in response to the events was not reported.  Based on comment, COVID-19 Causality Not applicable
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain; A spontaneous report was received from consumer, concerning Patient , of Unspecified age  Female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  pain in the same arm of the injection   The patient's medical history was not reported by a reporter.  On Unspecified Date to onset of events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection. and experienced  pain in the same arm of the injection  No Concomitant Medication was reported by reported.   No treatment information was provided.  Action taken with mRNA-1273 in response to events were not provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hypoaesthesia, Injection site pain, Joint stiffness, Neuralgia
Clinical narrative: plexus neuritis; pain radiated; pain moved to toes and ankle of the right leg; numbness in whole arm; nerve pain; Ankle froze up during walk; shoulder frozen; Painful in the joints, not just the injection site; arm sore; pinky and ring finger numbness; arm tingly; A spontaneous report was received from a consumer concerning a 45-year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273).  The patient's medical history was not included. Products known to have been used by the patient included unspecified multivitamins.  On 22 Jan 2021, prior to the onset of the events, the patient received one of two planned doses of mRNA-1273 (Lot number: 029L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.    On 22 Jan 2021, within hours of the mRNA-1273 vaccine being given, the patient noted that the arm was tingly, really sore, pinky and ring finger numbness and frozen shoulder. She noted it was painful in her joints and not just near the injection site.   On Monday, 25 Jan 2021, she sought medical attention at a clinic where they suggested the vaccine may have been administered too high into the shoulder. By Thursday of that week the pain did not clear up and she reported taking 4 ibuprofen every 4 hours for pain. The patient later saw an orthopedist who diagnosed her with plexus neuritis and recommended that the next shot to go into the glutes.   The following week, She reported that the pain radiated to her toes and ankles of the right leg. While the range of motion in her shoulder returned, she still had numbness and nerve issues in her whole arm and into the fingers as well as toes.   On 14 Feb 2021, while out for a walk, the patient felt her ankle freezing up which she described as "a cramp in her nerves, shooting pain through them. Treatment for the events included ibuprofen.   Action taken with mRNA-1273 is not applicable  The outcome of the events, tingly arm, arm sore, pinky and ring finer numbness, shoulder frozen, pain in joints, not just near injection site, Plexus neuritis, pain radiated, pain moved to toes and ankle of right leg, numbness in whole arm, ankle froze up during walk and nerve pain, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgic amyotrophy, Pain, Pain in extremity, Paraesthesia, Periarthritis
Clinical narrative: plexus neuritis; pain radiated; pain moved to toes and ankle of the right leg; numbness in whole arm; nerve pain; Ankle froze up during walk; shoulder frozen; Painful in the joints, not just the injection site; arm sore; pinky and ring finger numbness; arm tingly; A spontaneous report was received from a consumer concerning a 45-year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273).  The patient's medical history was not included. Products known to have been used by the patient included unspecified multivitamins.  On 22 Jan 2021, prior to the onset of the events, the patient received one of two planned doses of mRNA-1273 (Lot number: 029L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.    On 22 Jan 2021, within hours of the mRNA-1273 vaccine being given, the patient noted that the arm was tingly, really sore, pinky and ring finger numbness and frozen shoulder. She noted it was painful in her joints and not just near the injection site.   On Monday, 25 Jan 2021, she sought medical attention at a clinic where they suggested the vaccine may have been administered too high into the shoulder. By Thursday of that week the pain did not clear up and she reported taking 4 ibuprofen every 4 hours for pain. The patient later saw an orthopedist who diagnosed her with plexus neuritis and recommended that the next shot to go into the glutes.   The following week, She reported that the pain radiated to her toes and ankles of the right leg. While the range of motion in her shoulder returned, she still had numbness and nerve issues in her whole arm and into the fingers as well as toes.   On 14 Feb 2021, while out for a walk, the patient felt her ankle freezing up which she described as "a cramp in her nerves, shooting pain through them. Treatment for the events included ibuprofen.   Action taken with mRNA-1273 is not applicable  The outcome of the events, tingly arm, arm sore, pinky and ring finer numbness, shoulder frozen, pain in joints, not just near injection site, Plexus neuritis, pain radiated, pain moved to toes and ankle of right leg, numbness in whole arm, ankle froze up during walk and nerve pain, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Decreased appetite, Dizziness, Dysgeusia, Loss of personal independence in daily activities
Clinical narrative: Loss of taste; Loss of appetite; Could not use restroom; Smells like something is burning, or oil; has a metallic taste in her mouth; dizzy; tachycardia; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAROSMIA (Smells like something is burning, or oil), DYSGEUSIA (has a metallic taste in her mouth), DIZZINESS (dizzy), TACHYCARDIA (tachycardia) and AGEUSIA (Loss of taste) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cold, Blood pressure, Type 2 diabetes mellitus and Palpitations (Heart palpitations). Concomitant products included METFORMIN, LEVOTHYROXINE, AMLODIPINE BESILATE, OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL), BISOPROLOL FUMARATE and ALISKIREN for an unknown indication.    On 04-Feb-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PAROSMIA (Smells like something is burning, or oil), DYSGEUSIA (has a metallic taste in her mouth), DIZZINESS (dizzy) and TACHYCARDIA (tachycardia). On an unknown date, the patient experienced AGEUSIA (Loss of taste), DECREASED APPETITE (Loss of appetite) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not use restroom). At the time of the report, PAROSMIA (Smells like something is burning, or oil) and DYSGEUSIA (has a metallic taste in her mouth) outcome was unknown, DIZZINESS (dizzy) had not resolved and TACHYCARDIA (tachycardia), AGEUSIA (Loss of taste), DECREASED APPETITE (Loss of appetite) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not use restroom) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow up received on 27-APR-2021 and it contains significant information including concomitant medications, new events and change of event outcome. Other information updated include reporters information, patient demographics and patient medical history.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia, Tachycardia
Clinical narrative: Loss of taste; Loss of appetite; Could not use restroom; Smells like something is burning, or oil; has a metallic taste in her mouth; dizzy; tachycardia; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAROSMIA (Smells like something is burning, or oil), DYSGEUSIA (has a metallic taste in her mouth), DIZZINESS (dizzy), TACHYCARDIA (tachycardia) and AGEUSIA (Loss of taste) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cold, Blood pressure, Type 2 diabetes mellitus and Palpitations (Heart palpitations). Concomitant products included METFORMIN, LEVOTHYROXINE, AMLODIPINE BESILATE, OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL), BISOPROLOL FUMARATE and ALISKIREN for an unknown indication.    On 04-Feb-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PAROSMIA (Smells like something is burning, or oil), DYSGEUSIA (has a metallic taste in her mouth), DIZZINESS (dizzy) and TACHYCARDIA (tachycardia). On an unknown date, the patient experienced AGEUSIA (Loss of taste), DECREASED APPETITE (Loss of appetite) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not use restroom). At the time of the report, PAROSMIA (Smells like something is burning, or oil) and DYSGEUSIA (has a metallic taste in her mouth) outcome was unknown, DIZZINESS (dizzy) had not resolved and TACHYCARDIA (tachycardia), AGEUSIA (Loss of taste), DECREASED APPETITE (Loss of appetite) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not use restroom) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow up received on 27-APR-2021 and it contains significant information including concomitant medications, new events and change of event outcome. Other information updated include reporters information, patient demographics and patient medical history.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Torticollis
Clinical narrative: Acute torticollis; This spontaneous case was reported by a consumer and describes the occurrence of TORTICOLLIS (Acute torticollis) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced TORTICOLLIS (Acute torticollis). At the time of the report, TORTICOLLIS (Acute torticollis) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity, Pyrexia, Tenderness
Clinical narrative: 99.9°F Fever; Aches , joint pain , headaches; tenderness to touch; started to urinate frequently; sore arm; chills; A spontaneous report was received from a  consumer concerning an  68 -year old,  male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and    experienced  sore arm/ pain in extremity, chills, fever/ pyrexia, Aches , joint pain , headaches/ Pain, tenderness to touch/ tenderness, started to urinate frequently/ urine output,  The patient's medical history, was not provided by the reporter, included no known allergies,  Concomitant medications was  not reported.   On  13 Feb  2021prior to the onset of the symptoms, the patient received their First of two planned doses of mRNA-1273 (Batch number 013L20A)  for prophylaxis of COVID-19 infection.  On Unknown date after vaccination patient reported , the events sore arm, chills, fever, Aches , joint pain , headaches, tenderness to touch   Treatment information was not provided.  Action taken with mRNA-1273 in response to the events, was not provided.  The outcome of the events  sore arm, chills, fever, Aches , joint pain , headaches, tenderness to touch, started to urinate frequently Unknown